Astellas Pharma Inc.
4503.T·Tokyo
2,425.00+6.50 (+0.27%)today
At close: Oct 19, 3:30 PM JST · May be delayed up to 20 min · JPY
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close2,418.50
Open2,457.50
Day range2,412.502,458.00
52-week range1,557.502,717.00
Off day high−1.34%
Off 52-week high−10.75%
Volume4.72M
Avg. volume (3M)6.23M
Market cap4.35T
EPS (TTM)203.07
Forward P/E32.00
P/E ratio (TTM)11.94
Dividend yield3.31% (80.00)
Beta (5Y)—
Shares outstanding1.79B
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin—
Latest news
All 4503.T news ›Astellas Pharma Adopts Patient-Centric Strategy to Offset Patent Expirations
Astellas Pharma CEO Naoki Okamura has outlined a new corporate strategy centered on a “patient axis” operating model, an expanded portfolio of strategic brands, and the development of new scientific technologies to drive future growth. The…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
-
geneonline.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.